A while ago I posted something in which I commented that the deal with colintons was not a good one. I still believe that - and worse. These are the red flags for me:
- A deal which means whatever happens colintons is ok. In doing that deal the board effectively halved the value of the shares but obviously without a plan to recover.
- writing a response to legitimate questions from the ASX which makes no sense. I’m sure you’ve all read it but there are so many holes in the way it is written that it’s hard to feel anything other than despair about the competence of the board AND the executive team
i could go on but there’s little point. Mostly I feel sorry for those who are substantial shareholders, who kept ploughing money in and have borne the consequences of a series of problematic MDs who happily fed whatever fantasy had taken their fancy. Personally I think Rosheen ought to look for some board members who understand the realities of running a properly commercial organisation, who have an understanding of the speciality chemicals market and buying decisions, and have the ability to make independent decisions based on a rational analysis of the situation.
- Forums
- ASX - By Stock
- AJX
- Ann: Response to ASX Appendix 4C Query
Ann: Response to ASX Appendix 4C Query, page-44
-
- There are more pages in this discussion • 53 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AJX (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.18M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 186750 | 1.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.2¢ | 2629961 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 186750 | 0.011 |
5 | 4986365 | 0.010 |
3 | 511210 | 0.009 |
2 | 182600 | 0.008 |
1 | 200000 | 0.007 |
Price($) | Vol. | No. |
---|---|---|
0.012 | 2629961 | 3 |
0.013 | 1987914 | 4 |
0.014 | 134311 | 1 |
0.015 | 36316 | 2 |
0.017 | 15000 | 1 |
Last trade - 15.05pm 15/07/2024 (20 minute delay) ? |
Featured News
AJX (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online